Document is current
Any future updates will be listed below
-
Authors
Rashid-López, Raúl https://orcid.org/0000-0001-7319-4449
Macías-García, Paloma https://orcid.org/0000-0003-2643-1127
Cruz-Gómez, Álvaro J. https://orcid.org/0000-0001-9105-5100
Cano-Cano, Fátima https://orcid.org/0000-0002-7290-0812
Sánchez-Fernández, Francisco L. https://orcid.org/0000-0001-9517-5003
Sarrias-Arrabal, Esteban https://orcid.org/0000-0003-2050-2668
Del Marco, Ángel https://orcid.org/0000-0001-7911-2395
González-Moraleda, Álvaro https://orcid.org/0009-0005-7198-6641
Lozano-Soto, Elena https://orcid.org/0000-0002-8772-8584
Sanmartino, Florencia https://orcid.org/0000-0003-0651-8890
Espinosa-Rosso, Raúl https://orcid.org/0000-0002-0876-8378
González-Rosa, Javier J. https://orcid.org/0000-0002-5609-1103
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06840145 at ClinicalTrials.govDocuments that mention this clinical trial
Plasticity-Induced Motor Recovery of Bilateral Intermittent Theta Burst Stimulation in Parkinson’s Disease: A Randomized, Double-Blind, Sham-Controlled, Crossover Trial
https://doi.org/10.1007/s40120-025-00865-0
-
Funding
Funding for this research was provided by:
Ministerio de Ciencia, Innovación y Universidades (PID2021-124427OB-I00)
Ministerio de Ciencia, Innovación y Universidades (CNS2023-143743)
Ministerio de Ciencia, Innovación y Universidades (FJC2021-046990-I)
Consejería de Salud y Familias, Junta de Andalucía (ProyExcel-01041)
Universidad de Cádiz (Plan CIE Estabiliza” Program)
- License Information
-
More Information
Article History
Received: 29 September 2025
Accepted: 12 November 2025
First Online: 6 December 2025
Declarations
:
: Raúl Rashid-López and Raúl Espinosa-Rosso have received speaker fees from Teva, AbbVie, Zambon, BIAL, Lundbeck, and Italfarmaco. Javier J. González-Rosa has received speaker fees from Lundbeck. Raúl Rashid-López, Raúl Espinosa-Rosso, and Javier J. González-Rosa received travel support and training from Medtronic, but this support was not related to this study. Paloma Macías-García, Álvaro J. Cruz-Gómez, Fátima Cano-Cano, F. Luis Sánchez-Fernández, Esteban Sarrias-Arrabal, Angel Del Marco, Álvaro González-Moraleda, Elena Lozano-Soto, and Florencia Sanmartino state that no commercial or financial relationships that might be considered potential conflicts of interest existed during the current research.
: The study was approved by the Andalusian Biomedical Research Ethics Committee (reference no. 2169-N-19) on April 1, 2020, in accordance with the Declaration of Helsinki and its later amendments. Written informed consent was obtained from all participants following comprehensive protocol disclosure prior to study enrollment.
